For Immediate Release
Posted: December 28, 2020


Communications Director
6032712121 |

13 Vaccination Sites to Open for First Responders, Ambulatory Care Providers

Concord, NH - Tomorrow, 13 sites across New Hampshire will open to begin vaccinating first responders and high-risk ambulatory care providers as part of Phase 1A of the state’s vaccination plan.

“Throughout this pandemic, New Hampshire’s first responders and ambulatory care providers have ensured the safety and wellbeing of our communities without hesitation,” said Governor Chris Sununu. “From the day the first doses of the COVID-19 vaccines arrived in the Granite State, we hit the ground running to get the doses out the door and into the arms of our highest risk health care providers and long-term care residents. The State of New Hampshire will continue to make this vaccine available as quickly and efficiently as possible.”

“We are making great strides in deploying the COVID-19 vaccine to people working on the front lines and at highest risk of exposure. We have heard from many first responders and high-risk healthcare workers who work directly with patients and are scheduling their vaccine appointments starting tomorrow,” said DHHS Commissioner Lori Shibinette. “This represents another important milestone in ending the pandemic in New Hampshire. On behalf of everyone at DHHS, I wish to thank the National Guard and the Regional Public Health Networks for supporting the operation of the community vaccination sites.”

First responders eligible to be vaccinated under Phase 1A will be alerted to schedule a vaccination appointment through professional associations, licensing boards, provider groups, and first responder organizations.

13 clinic locations will open across the state in the following communities:

  • Claremont
  • Concord
  • Exeter
  • Hooksett
  • Keene
  • Laconia
  • Lebanon
  • Littleton
  • Londonderry
  • Nashua
  • Plymouth
  • Rochester
  • Tamworth

Based on population density, 7 vaccination sites will operate five days a week, with 6 vaccination sites operating 2-3 days of the week.

In total, Phase 1A includes approximately 110,000 individuals and is expected to be completed by mid-January.